Exelixis Intellectual Property Contracts & Agreements

13 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited (Cabozantinib in Japan)
License Agreements
Exelixis
Biotechnology
DE
2022
Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS (Cabozantinib)
License Agreements
Exelixis
Biotechnology
NY
2021
Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited (Cabozantinib in Japan)
License Agreements
Exelixis
Biotechnology
DE
2017
Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS (Cabozantinib)
License Agreements
Exelixis
Biotechnology
NY
2016
Exclusive License Agreement between Exelixis, Inc. and Merck Sharp & Dohme Corp.
License Agreements
Exelixis
Biotechnology
2012
Amended and Restated License Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
License Agreements
Exelixis
Biotechnology
DE
2011
License Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (October 8, 2010)
License Agreements
Exelixis
Biotechnology
DE
2011
License Agreement between Exelixis, Inc. and Sanofi-Aventis dated May 27, 2009
License Agreements
Exelixis
Biotechnology
NY
2009
License Agreement between Exelixis, Inc., X-Ceptor Therapeutics, Inc., and Wyeth Pharmaceuticals Division
License Agreements
Exelixis
Biotechnology
NY
2006
Novated and Restated Technology License Agreement among Exelixis, Inc., Symphony Evolution, Inc., and Symphony Evolution Holdings LLC
License Agreements
Exelixis
Biotechnology
DE
2005
License Agreement between Exelixis, Inc. and Helsinn Healthcare S.A. for Becatecarin Development and Commercialization
License Agreements
Exelixis
Biotechnology
WA
2005
Software License and Asset Acquisition Agreement between Exelixis, Inc. and Visualize Inc.
License Agreements
Exelixis
Biotechnology
2002
License Agreement Between Exelixis, Inc. and Bristol-Myers Squibb Company for Rebeccamycin
License Agreements
Exelixis
Biotechnology
2001